ATPase
ATPase is a class of enzymes that catalyze the decomposition of ATP into ADP and a free phosphate ion, including some co-transporters and pumps.
Products Related to ATPase(77)
- GC16533Oligomycin ComplexCAS: 1404-19-9Purity: >98.00%
Oligomycin complex consists of a blend of oligomycins A, B, and C.
- GC16859Oligomycin ACAS: 579-13-5Purity: >98.00%
Oligomycin A is an inhibitor of ATP synthase, which inhibits the process taking place on mitochondria coupling membrane that depended on ATP and oxidative phosphorylation.
- GC17225ARL 67156 trisodium saltCAS: 1021868-83-6Purity: >98.00%
ARL 67156 trisodium salt is a selective inhibitor of ecto-ATPases.
- GC18105EnterostatinCAS: 117830-79-2Purity: >98.00%
Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
- GC18474AcetyldigitoxinCAS: 1111-39-3Purity: >95.00%
Acetyldigitoxin is cardiac glycoside and an inhibitor of the Na+/K+ ATPase with an IC50 value of 5 nM in isolated rat pinealocytes.
- GC18583D-α-Hydroxyglutaric AcidCAS: 13095-47-1Purity: >98.00%
D-α-Hydroxyglutaric Acid is a weak competitive antagonist of α‑ketoglutarate (α‑KG) (K i = 10.87mM).
- GC25991TetrathiomolybdateCAS: 16330-92-0
Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson's disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
- GC35421ATP synthase inhibitor 1CAS: 1023043-30-2Purity: >99.50%
ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels.
- GC40434(±)16-HETECAS: 128914-46-5Purity: >98.00%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.
- GC4045316(R)-HETECAS: 183509-22-0Purity: >95.00%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.
- GC4045416(S)-HETECAS: 183509-23-1Purity: >98.00%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.
- GC4045517(R)-HETECAS: 183509-24-2Purity: >98.00%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.
- GC4045617(S)-HETECAS: 183509-25-3Purity: >98.00%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.
- GC41091(S)-LansoprazoleCAS: 138530-95-7Purity: >98.00%
(S)-Lansoprazole is a proton pump inhibitor that irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50 = 5.2 μM), inhibiting gastric acid secretion and increasing intragastric pH.
- GC41484(S)-3'-hydroxy BlebbistatinCAS: 2097136-42-8Purity: >95.00%
(S)-3'-hydroxy Blebbistatin is a more stable and less phototoxic form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases.
- GC41557(S)-3'-amino BlebbistatinCAS: 2097141-18-7Purity: >95.00%
(S)-3'-amino Blebbistatin is a more stable and less phototoxic form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases.
- GC41719(R)-nitro-BlebbistatinCAS: 1217619-62-9Purity: >98.00%
(R)-nitro-Blebbistatin is a more stable form of (+)-blebbistatin, which is the inactive form of (-)-blebbistatin.
- GC41739(S)-nitro-BlebbistatinCAS: 856925-75-2Purity: >98.00%
(S)-nitro-Blebbistatin is a more stable form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16221 | Oligomycin C | 11052-72-5 | >98% | |
mitochondrial F1FO-ATP synthase inhibitor | ||||
| GC16409 | Oligomycin B | 11050-94-5 | >85.00% | |
mitochondrial F1FO ATP synthase inhibitor | ||||
| GC16533 | Oligomycin Complex | 1404-19-9 | >98.00% | |
Oligomycin complex consists of a blend of oligomycins A, B, and C. | ||||
| GC16859 | Oligomycin A | 579-13-5 | >98.00% | |
Oligomycin A is an inhibitor of ATP synthase, which inhibits the process taking place on mitochondria coupling membrane that depended on ATP and oxidative phosphorylation. | ||||
| GC17027 | POM 1 | 12141-67-2 | >98.00% | |
POM 1 is a nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitor with K i values of 2.58μM, 3.26μM and 28.8μM for NTPDase1 (CD39), NTPDase3 and NTPDase2, respectively. | ||||
| GC17225 | ARL 67156 trisodium salt | 1021868-83-6 | >98.00% | |
ARL 67156 trisodium salt is a selective inhibitor of ecto-ATPases. | ||||
| GC17786 | Istaroxime hydrochloride | 374559-48-5 | >99.00% | |
| GC18005 | Tenatoprazole | 113712-98-4 | >98.00% | |
proton pump inhibitor | ||||
| GC18105 | Enterostatin | 117830-79-2 | >98.00% | |
Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake. | ||||
| GC18474 | Acetyldigitoxin | 1111-39-3 | >95.00% | |
Acetyldigitoxin is cardiac glycoside and an inhibitor of the Na+/K+ ATPase with an IC50 value of 5 nM in isolated rat pinealocytes. | ||||
| GC18583 | D-α-Hydroxyglutaric Acid | 13095-47-1 | >98.00% | |
D-α-Hydroxyglutaric Acid is a weak competitive antagonist of α‑ketoglutarate (α‑KG) (K i = 10.87mM). | ||||
| GC25991 | Tetrathiomolybdate | 16330-92-0 | - | |
Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson's disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster. | ||||
| GC33234 | Gboxin | 2101315-36-8 | >98.00% | |
Gboxin is an inhibitor of oxidative phosphorylation (OXPHOS) in cancer cells and can be targeted to inhibit glioblastoma (GBM). | ||||
| GC35421 | ATP synthase inhibitor 1 | 1023043-30-2 | >99.50% | |
ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels. | ||||
| GC40434 | (±)16-HETE | 128914-46-5 | >98.00% | |
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. | ||||
| GC40453 | 16(R)-HETE | 183509-22-0 | >95.00% | |
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. | ||||
| GC40454 | 16(S)-HETE | 183509-23-1 | >98.00% | |
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. | ||||
| GC40455 | 17(R)-HETE | 183509-24-2 | >98.00% | |
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. | ||||
| GC40456 | 17(S)-HETE | 183509-25-3 | >98.00% | |
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. | ||||
| GC41091 | (S)-Lansoprazole | 138530-95-7 | >98.00% | |
(S)-Lansoprazole is a proton pump inhibitor that irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50 = 5.2 μM), inhibiting gastric acid secretion and increasing intragastric pH. | ||||
| GC41484 | (S)-3'-hydroxy Blebbistatin | 2097136-42-8 | >95.00% | |
(S)-3'-hydroxy Blebbistatin is a more stable and less phototoxic form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases. | ||||
| GC41557 | (S)-3'-amino Blebbistatin | 2097141-18-7 | >95.00% | |
(S)-3'-amino Blebbistatin is a more stable and less phototoxic form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases. | ||||
| GC41719 | (R)-nitro-Blebbistatin | 1217619-62-9 | >98.00% | |
(R)-nitro-Blebbistatin is a more stable form of (+)-blebbistatin, which is the inactive form of (-)-blebbistatin. | ||||
| GC41739 | (S)-nitro-Blebbistatin | 856925-75-2 | >98.00% | |
(S)-nitro-Blebbistatin is a more stable form of (-)-blebbistatin, which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases. | ||||